NCT07226687

Brief Summary

To evaluate the impact of sustainable functional urethral reconstruction (SFUR) on early recovery of urinary continence (UC) after robot-assisted radical prostatectomy.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
58mo left

Started Sep 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 10, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2031

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2031

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

4.7 years

First QC Date

September 23, 2025

Last Update Submit

February 13, 2026

Conditions

Keywords

ProstatectomyUrinary continence

Outcome Measures

Primary Outcomes (1)

  • Evaluating the impact of the urethral bites

    To evaluate the impact of small versus large urethral bites during vesicourethral anastomosis on urinary continence at 6 months following Robotic-assisted radical prostatectomy (RARP). Specifically, we aim to determine whether a smaller or larger suture bite technique results in superior continence recovery. This will be measured by comparing the number of incontinence pads that are needed to be used per day between each group.

    6 months following RARP

Secondary Outcomes (2)

  • Assessment of urinary leaks and complications

    3 months following surgery

  • Assessment of urinary leaks and complications

    12 months following surgery

Study Arms (2)

Small Bites

EXPERIMENTAL

Patients will undergo Robotic-assisted radical prostatectomy (RARP) with vesicourethral anastomosis using small urethral bites, as determined by the surgeon, with goal of being approximately 5-7 mm from the cut edge of the urethra.

Procedure: Small Urethral Bite Technique

Large Bites

EXPERIMENTAL

Patients will undergo Robotic-assisted radical prostatectomy (RARP) with vesicourethral anastomosis using large urethral bites, as determined by the surgeon, with goal of being approximately 15-20 mm from the cut edge of the urethra.

Procedure: Large Urethral Bite Technique

Interventions

The small urethral bite technique involves placing sutures (stitches) that are \~5-7 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Small Bites

The large urethral bite technique involves placing sutures (stitches) that are \~15-20 mm from the edge of the urethra. Each suture penetrates the full thickness of the urethra.

Large Bites

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients aged 18 years and older.
  • Diagnosis of prostate cancer with an indication for robotic-assisted radical prostatectomy (RARP).
  • Ability to provide informed consent.

You may not qualify if:

  • History of pelvic radiation therapy
  • Prostatectomy performed in the context of salvage therapy (e.g., post-radiation or post-focal therapy)
  • Presence of extra-pelvic metastatic disease
  • Neurological disorders significantly affecting continence (e.g., severe Parkinson's disease, multiple sclerosis)
  • Pre-existing urinary incontinence
  • Inability to comply with follow-up protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, 60637, United States

Location

Study Officials

  • Scott Eggener

    University of Chicago

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2025

First Posted

November 10, 2025

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

May 23, 2031

Study Completion (Estimated)

May 23, 2031

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations